An Oncogene-Induced DNA Damage Model for Cancer Development

  title={An Oncogene-Induced DNA Damage Model for Cancer Development},
  author={Thanos D Halazonetis and Vassilis G. Gorgoulis and Jiri Bartek},
  pages={1352 - 1355}
Of all types of DNA damage, DNA double-strand breaks (DSBs) pose the greatest challenge to cells. One might have, therefore, anticipated that a sizable number of DNA DSBs would be incompatible with cell proliferation. Yet recent experimental findings suggest that, in both precancerous lesions and cancers, activated oncogenes induce stalling and collapse of DNA replication forks, which in turn leads to formation of DNA DSBs. This continuous formation of DNA DSBs may contribute to the genomic… 

DNA damage in cancer development: special implications in viral oncogenesis.

Discovering that a certain DNA damaging agent increases the likelihood of viral integration will enable the development of prophylactic and therapeutic strategies designed specifically to prevent such integration, with the ultimate goal of reducing or eliminating these viral-induced malignancies.

The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress

This work shows that DEK facilitates cellular proliferation under conditions of DNA replication stress by promoting replication fork progression and protects from the transmission of DNA damage to the daughter cell generation.

Tumor promoting role of the DNA damage response

The imposition of low levels of genotoxic stress on AML derived leukemic cells rendered them unable to self-renew and instead promoted their differentiation to mature myeloid cells.

Targeting DNA double-strand break signalling and repair: recent advances in cancer therapy.

The latest preclinical and clinical developments in cancer therapy based on the current knowledge of DSB signalling and repair are summarized, with a special focus on the combination of small molecule inhibitors with synthetic lethality approaches.

Increasing sensitivity to DNA damage is a potential driver for human ovarian cancer

It is proposed that accumulated DNA lesions might be a potential driver of ovarian cancer and the impaired DNA damage responders could be the targets for clinical treatment.

Role of DNA damage response pathways in preventing carcinogenesis caused by intrinsic replication stress

Under conditions of systemic replication stress, the ATM pathway is particularly important both for cancer suppression and viability during development, suggesting that ATM drug inhibitors might be useful against tumors with DNA replication defects.

Critical DNA damaging pathways in tumorigenesis.

Cell cycle- and DNA repair pathway-specific effects of apoptosis on tumor suppression

It is concluded that the oncogenic potential of double-strand breaks resulting from NHEJ deficiency is highly restricted by nonapoptotic functions of p53, suggesting that the particular facets of the DNA damage response required for tumor suppression are dictated by the proliferative status of the tumor-initiating cell.

H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy

Analysis of γH2AX expression can be used to detect the genotoxic effect of different toxic substances and to predict of tumor cell sensitivity to DNA damaging anticancer agents and toxicity of anticancer treatment toward normal cells.

Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cells

Evidence is provided that ionizing radiation (IR)-induced DNA damage elicits a tumorigenic behavior in terms of E-cadherin delocalization, cell delamination, basement membrane degradation and neoplasic overgrowth and a tumor suppressor role of apoptosis, DNA repair by HR and cell cycle arrest in G2 in simple epithelia subject to IR.



Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

It is proposed that, from its earliest stages, cancer development is associated with DNA replication stress, which leads to DNA double-strand breaks, genomic instability and selective pressure for p53 mutations.

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

It is shown that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks, and, together with apoptosis, provides a barrier to malignant progression.

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

It is shown that in clinical specimens from different stages of human tumours of the urinary bladder, breast, lung and colon, the early precursor lesions commonly express markers of an activated DNA damage response.

Ras induces chromosome instability and abrogation of the DNA damage response.

Data show that acute expression of activated Ras is sufficient to induce chromosomal instability in the absence of other signals, and suggest that Ras-induced chromosome instability arises as a consequence of defects in the processing of DNA damage.

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

It is shown that the p53-mediated pathological response to whole-body irradiation, a prototypical genotoxic carcinogen, is irrelevant for suppression of radiation-induced lymphoma, and delaying the restoration of p53 function until the acute radiation response has subsided abrogates all of the radiation- induced pathology yet preserves much of the protection from lymphoma.

A DNA damage checkpoint response in telomere-initiated senescence

It is proposed that telomere-initiated senescence reflects a DNA damage checkpoint response that is activated with a direct contribution from dysfunctional telomeres.

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

It is proposed that p53 helps maintain genetic stability in NDF by mediating a permanent cell cycle arrest through long-term induction of Cip1 when low amounts of unrepaired DNA damage are present in G1 before the restriction point.

Oncogenes and the DNA Damage Response: Myc and E2F1 Engage the ATM Signaling Pathway to Activate p53 and Induce Apoptosis

It is demonstrated that ATM does indeed function to suppress tumorigenesis by responding to at least some oncogenic stresses and what generates the selective pressure for p53 inactivation during tumorigenesis is explained.

Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.

Findings reveal that telomere shortening is a defining somatic DNA alteration characterizing HGPIN, suggesting that the earliest phase of human prostate carcinogenesis may proceed as a consequence of chromosomal instability mediated by shortened, dysfunctional telomeres.